Relationship between Muscle Mass/Strength and Hepatic Fat Content in Post-Menopausal Women
Abstract
:1. Introduction
2. Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
Abbreviations
1H MRS | single-voxel proton magnetic resonance spectroscopy |
ASM% | appendicular skeletal muscular mass index; ASM% = appendicular lean mass/weight × 100% |
BMI | body mass index |
Felbow | elbow flexion force |
FFA | free fatty acids |
Fgrip | hand grip force |
Fknee | knee extension force |
FPG | fasting plasma glucose |
FSH | follicle-stimulating hormone |
HFC | hepatic fat content |
HOMA-IR | homeostatic model assessment of insulin resistance |
HYB | hybrid exercise training |
IR | insulin resistance |
NAFLD | non-alcoholic fatty liver disease |
NASH | non-alcoholic steatohepatitis |
SMI% | skeletal muscle index; SMI% = total lean mass/weight × 100% |
Wt | weight |
References
- Li, Z.; Xue, J.; Chen, P.; Chen, L.; Yan, S.; Liu, L. Prevalence of nonalcoholic fatty liver disease in mainland of China: A meta-analysis of published studies. J. Gastroenterol. Hepatol. 2014, 29, 42–51. [Google Scholar] [CrossRef] [PubMed]
- Wang, C.; Bai, L. Sarcopenia in the elderly: Basic and clinical issues. Geriatr. Gerontolog. Int. 2012, 12, 388–396. [Google Scholar] [CrossRef] [PubMed]
- Takamura, T.; Misu, H.; Ota, T.; Kaneko, S. Fatty liver as a consequence and cause of insulin resistance: Lessons from type 2 diabetic liver. Endocr. J. 2012, 59, 745–763. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Flannery, C.; Dufour, S.; Rabol, R.; Shulman, G.I.; Petersen, K.F. Skeletal muscle insulin resistance promotes increased hepatic de novo lipogenesis, hyperlipidemia, and hepatic steatosis in the elderly. Diabetes 2012, 61, 2711–2717. [Google Scholar] [CrossRef] [PubMed]
- Jornayvaz, F.R.; Samuel, V.T.; Shulman, G.I. The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome. Annu. Rev. Nutr. 2010, 30, 273–290. [Google Scholar] [CrossRef] [PubMed]
- Fryburg, D.A.; Barrett, E.J.; Louard, R.J.; Gelfand, R.A. Effect of starvation on human muscle protein metabolism and its response to insulin. Am. J. Physiol. 1990, 259, E477–E482. [Google Scholar] [CrossRef] [PubMed]
- Balage, M.; Sinaud, S.; Prod’homme, M.; Dardevet, D.; Vary, T.C.; Kimball, S.R.; Jefferson, L.S.; Grizard, J. Amino acids and insulin are both required to regulate assembly of the eIF4E. eIF4G complex in rat skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2001, 281, E565–E574. [Google Scholar] [CrossRef] [PubMed]
- Volpi, E.; Mittendorfer, B.; Rasmussen, B.B.; Wolfe, R.R. The response of muscle protein anabolism to combined hyperaminoacidemia and glucose-induced hyperinsulinemia is impaired in the elderly. J. Clin. Endocrinol. Metab. 2000, 85, 4481–4490. [Google Scholar] [CrossRef] [PubMed]
- Moon, J.S.; Yoon, J.S.; Won, K.C.; Lee, H.W. The role of skeletal muscle in development of nonalcoholic Fatty liver disease. Diabetes Metab. J. 2013, 37, 278–285. [Google Scholar] [CrossRef]
- Hong, H.C.; Hwang, S.Y.; Choi, H.Y.; Yoo, H.J.; Seo, J.A.; Kim, S.G.; Kim, N.H.; Baik, S.H.; Choi, D.S.; Choi, K.M. Relationship between sarcopenia and nonalcoholic fatty liver disease: The Korean Sarcopenic Obesity Study. Hepatology 2014, 59, 1772–1778. [Google Scholar] [CrossRef]
- Kitajima, Y.; Eguchi, Y.; Ishibashi, E.; Nakashita, S.; Aoki, S.; Toda, S.; Mizuta, T.; Ozaki, I.; Ono, N.; Eguchi, T.; et al. Age-related fat deposition in multifidus muscle could be a marker for nonalcoholic fatty liver disease. J. Gastroenterol. 2010, 45, 218–224. [Google Scholar] [CrossRef]
- Croymans, D.M.; Paparisto, E.; Lee, M.M.; Brandt, N.; Le, B.K.; Lohan, D.; Lee, C.C.; Roberts, C.K. Resistance training improves indices of muscle insulin sensitivity and beta-cell function in overweight/obese, sedentary young men. J. Appl. Physiol. 2013, 115, 1245–1253. [Google Scholar] [CrossRef] [PubMed]
- Hallsworth, K.; Fattakhova, G.; Hollingsworth, K.G.; Thoma, C.; Moore, S.; Taylor, R.; Day, C.P.; Trenell, M.I. Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss. Gut 2011, 60, 1278–1283. [Google Scholar] [CrossRef]
- Oh, S.; Maruyama, T.; Eguchi, K.; Shida, T.; Arai, E.; Isobe, T.; Okamoto, Y.; Shoda, J. Therapeutic effect of hybrid training of voluntary and electrical muscle contractions in middle-aged obese women with nonalcoholic fatty liver disease: A pilot trial. Ther. Clin. Risk Manag. 2015, 11, 371–380. [Google Scholar] [CrossRef] [PubMed]
- Krasnoff, J.B.; Painter, P.L.; Wallace, J.P.; Bass, N.M.; Merriman, R.B. Health-related fitness and physical activity in patients with nonalcoholic fatty liver disease. Hepatology 2008, 47, 1158–1166. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Liu, Q.; Bengmark, S.; Qu, S. The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD). Lipids Health Dis. 2010, 9, 42. [Google Scholar] [CrossRef] [PubMed]
- Fan, J.G.; Zhu, J.; Li, X.J.; Chen, L.; Li, L.; Dai, F.; Li, F.; Chen, S.Y. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J. Hepatol. 2005, 43, 508–514. [Google Scholar] [CrossRef] [PubMed]
- Kojima, S.; Watanabe, N.; Numata, M.; Ogawa, T.; Matsuzaki, S. Increase in the prevalence of fatty liver in Japan over the past 12 years: Analysis of clinical background. J. Gastroenterol. 2003, 38, 954–961. [Google Scholar] [CrossRef] [PubMed]
- Zhou, Y.J.; Li, Y.Y.; Nie, Y.Q.; Ma, J.X.; Lu, L.G.; Shi, S.L.; Chen, M.H.; Hu, P.J. Prevalence of fatty liver disease and its risk factors in the population of South China. World J. Gastroenterol. 2007, 13, 6419–6424. [Google Scholar] [CrossRef] [PubMed]
- Gutierrez-Grobe, Y.; Ponciano-Rodriguez, G.; Ramos, M.H.; Uribe, M.; Mendez-Sanchez, N. Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens. Ann. Hepatol. 2010, 9, 402–409. [Google Scholar] [CrossRef]
- Sanyal, A.J.; Brunt, E.M.; Kleiner, D.E.; Kowdley, K.V.; Chalasani, N.; Lavine, J.E.; Ratziu, V.; McCullough, A. Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology 2011, 54, 344–353. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Borra, R.J.; Salo, S.; Dean, K.; Lautamaki, R.; Nuutila, P.; Komu, M.; Parkkola, R. Nonalcoholic fatty liver disease: Rapid evaluation of liver fat content with in-phase and out-of-phase MR imaging. Radiology 2009, 250, 130–136. [Google Scholar] [CrossRef] [PubMed]
- Provencher, S.W. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed. 2001, 14, 260–264. [Google Scholar] [CrossRef] [PubMed]
- Matthews, D.R.; Hosker, J.P.; Rudenski, A.S.; Naylor, B.A.; Treacher, D.F.; Turner, R.C. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28, 412–419. [Google Scholar] [CrossRef] [PubMed]
- Boirie, Y. Insulin regulation of mitochondrial proteins and oxidative phosphorylation in human muscle. Trends Endocrinol. Metab. TEM 2003, 14, 393–394. [Google Scholar] [CrossRef] [PubMed]
- Montgomery, M.K.; Turner, N. Mitochondrial dysfunction and insulin resistance: An update. Endocr. Connect. 2015, 4, R1–R15. [Google Scholar] [CrossRef] [PubMed]
- Biddinger, S.B.; Hernandez-Ono, A.; Rask-Madsen, C.; Haas, J.T.; Aleman, J.O.; Suzuki, R.; Scapa, E.F.; Agarwal, C.; Carey, M.C.; Stephanopoulos, G.; et al. Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell Metab. 2008, 7, 125–134. [Google Scholar] [CrossRef] [PubMed]
- Koo, S.H.; Satoh, H.; Herzig, S.; Lee, C.H.; Hedrick, S.; Kulkarni, R.; Evans, R.M.; Olefsky, J.; Montminy, M. PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3. Nat. Med. 2004, 10, 530–534. [Google Scholar] [CrossRef] [PubMed]
- Srikanthan, P.; Karlamangla, A.S. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey. J. Clin. Endocrinol. Metab. 2011, 96, 2898–2903. [Google Scholar] [CrossRef]
- Kim, J.A.; Wei, Y.; Sowers, J.R. Role of mitochondrial dysfunction in insulin resistance. Circ. Res. 2008, 102, 401–414. [Google Scholar] [CrossRef]
- Leong, D.P.; Teo, K.K.; Rangarajan, S.; Lopez-Jaramillo, P.; Avezum, A., Jr.; Orlandini, A.; Seron, P.; Ahmed, S.H.; Rosengren, A.; Kelishadi, R.; et al. Prognostic value of grip strength: Findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet 2015, 386, 266–273. [Google Scholar] [CrossRef]
- Barbat-Artigas, S.; Rolland, Y.; Cesari, M.; Abellan van Kan, G.; Vellas, B.; Aubertin-Leheudre, M. Clinical relevance of different muscle strength indexes and functional impairment in women aged 75 years and older. J. Gerontol. Series A Biol. Sci. Med. Sci. 2013, 68, 811–819. [Google Scholar] [CrossRef] [PubMed]
- Pedersen, B.K.; Febbraio, M.A. Muscles, exercise and obesity: Skeletal muscle as a secretory organ. Nat. Rev. Endocrinol. 2012, 8, 457–465. [Google Scholar] [CrossRef] [PubMed]
- Bradbury, M.W. Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: Possible role in steatosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290, G194–G198. [Google Scholar] [CrossRef]
- Okamoto, Y.; Kemp, G.J.; Isobe, T.; Sato, E.; Hirano, Y.; Shoda, J.; Minami, M. Changes in diffusion tensor imaging (DTI) eigenvalues of skeletal muscle due to hybrid exercise training. Magn. Reson. Imaging 2014, 32, 1297–1300. [Google Scholar] [CrossRef]
- Abenavoli, L.; Pellicano, R.; Boccuto, L. Role of genetic and metabolism in non-alcoholic fatty liver disease. Panminerva Med. 2018, 60, 41–43. [Google Scholar] [CrossRef]
G0 | G1 | G2 | G3 | |
---|---|---|---|---|
(HFC < 5%) | (5 ≤ HFC < 10%) | (10 ≤ HFC < 25%) | (HFC ≥ 25%) | |
N | 20 | 27 | 31 | 18 |
Age (years) | 60.1 ± 3.9 | 60.2 ± 3.9 | 59.6 ± 3.7 | 58.7 ± 2.9 |
Height (cm) | 159.1 ± 5.5 | 158.8 ± 5.2 | 158.1 ± 5.6 | 158.2 ± 8.1 |
Weight (kg) | 60.9 ± 8.4 | 64.5 ± 8.4 | 68.1 ± 8.1 a | 68.0 ± 9.6 c |
BMI (kg/m2) | 24.1 ± 2.8 | 25.6 ± 3.2 | 27.2 ± 2.5 a,b | 27.1 ± 2.7 c |
FPG (mmol/L) | 5.61 ± 0.56 | 5.61 ± 0.69 | 5.43 ± 0.72 | 5.47 ± 0.77 |
Insulin (mIU/L) | 11.27 ± 4.78 | 13.48 ± 7.66 | 18.18 ± 8.99 a,b | 21.47 ± 11.74c,d |
HOMA-IR | 2.83 ± 1.26 | 3.52 ± 2.17 | 4.55 ± 2.51 a | 5.05 ± 2.35 c,d |
FSH (mIU/mL) | 65.3 ± 24.5 | 52.6 ± 15.5 | 51.9 ± 25.6 a | 44.8 ± 18.0 c |
G0 | G1 | G2 | G3 | |
---|---|---|---|---|
(HFC < 5%) | (5 ≤ HFC < 10%) | (10 ≤ HFC < 25%) | (HFC ≥ 25%) | |
N | 20 | 27 | 31 | 18 |
Fgrip /Wt (%) | 42.3 ± 7.2 | 42.8 ± 8.2 | 41.0 ± 8.0 | 36.3 ± 8.6 c,d |
Felbow/Wt (%) | 29.0 ± 3.9 | 29.9 ± 4.6 | 27.7 ± 4.7 | 28.2 ± 5.1 |
Fknee /Wt (%) | 48.6 ± 9.7 | 49.6 ± 12.1 | 43.7 ± 8.9 b | 43.4 ± 12.3 |
SMI (%) | 59.6 ± 3.6 | 58.8 ± 2.8 | 56.7 ± 3.5a,b | 57.0 ± 2.8 c |
ASM (%) | 26.0 ± 2.1 | 25.6 ± 1.9 | 24.9 ± 1.8 | 25.0 ± 1.8 |
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Zhang, Y.; Lu, D.; Wang, R.; Fu, W.; Zhang, S. Relationship between Muscle Mass/Strength and Hepatic Fat Content in Post-Menopausal Women. Medicina 2019, 55, 629. https://doi.org/10.3390/medicina55100629
Zhang Y, Lu D, Wang R, Fu W, Zhang S. Relationship between Muscle Mass/Strength and Hepatic Fat Content in Post-Menopausal Women. Medicina. 2019; 55(10):629. https://doi.org/10.3390/medicina55100629
Chicago/Turabian StyleZhang, Yajie, Dajiang Lu, Renwei Wang, Weijie Fu, and Shengnian Zhang. 2019. "Relationship between Muscle Mass/Strength and Hepatic Fat Content in Post-Menopausal Women" Medicina 55, no. 10: 629. https://doi.org/10.3390/medicina55100629